The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis.

MLA

Whitfield, Michael G., et al. “The Potential Use of Rifabutin for Treatment of Patients Diagnosed with Rifampicin-Resistant Tuberculosis.” Journal of Antimicrobial Chemotherapy (JAC), vol. 73, no. 10, Oct. 2018, pp. 2667–74. EBSCOhost, https://doi.org/10.1093/jac/dky248.

APA

Whitfield, M. G., Warren, R. M., Mathys, V., Scott, L., Vos, E. D., Stevens, W., Streicher, E. M., Groenen, G., Sirgel, F. A., Rie, A. V., De Vos, E., & Van Rie, A. (2018). The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis. Journal of Antimicrobial Chemotherapy (JAC), 73(10), 2667–2674. https://doi.org/10.1093/jac/dky248

Chicago

Whitfield, Michael G, Robin M Warren, Vanessa Mathys, Lesley Scott, Elise De Vos, Wendy Stevens, Elizabeth M Streicher, et al. 2018. “The Potential Use of Rifabutin for Treatment of Patients Diagnosed with Rifampicin-Resistant Tuberculosis.” Journal of Antimicrobial Chemotherapy (JAC) 73 (10): 2667–74. doi:10.1093/jac/dky248.